A single-center prospective observational study of stereotactic radiotherapy for bone metastasis

A single-center prospective observational study of stereotactic radiotherapy for bone metastasis - A single-center prospective observational study of stereotactic radiotherapy for bone metastasis

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000055061

Enrollment

Registered

2024-07-24

Start date

2024-07-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone metastasis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients receive stereotactic radiotherapy for bone metastasis 2) Age <= 20 years old 3) Written informed consent

Exclusion criteria

Exclusion criteria: 1) Unable to receive stereotactic radiotherapy 2) Unable to obtain written informed consent 3) Inappropriate patients for this study judged by physicians

Design outcomes

Primary

Measure	Time frame
Proportion of bone fracture	—

Secondary

Measure	Time frame
Overall survival, local control period	—

Countries

Japan

Contacts

Public ContactShigeo TAKAHASHI

Kagawa University Hospital Department of Radiation Oncology

takahashi.shigeo@kagawa-u.ac.jp087-898-5111

Outcome results